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Actinorhodin (ACT) produced byStreptomyces coeli-
color A3(2) belongs to the benzoisochromanequi-
none (BIQ) class of antibiotics. ActVA-ORF5, a
flavin-dependent monooxygenase (FMO) essential
for ACT biosynthesis, forms a two-component
enzyme system in combination with a flavin:NADH
oxidoreductase, ActVB. The genes for homologous
two-component FMOs are found in the biosynthetic
gene clusters for two other BIQs, granaticin (GRA)
and medermycin (MED), and a closely related antibi-
otic, alnumycin (ALN). Our functional analysis of
these FMOs (ActVA-ORF5, Gra-ORF21, Med-ORF7,
and AlnT) in S. coelicolor unambiguously demon-
strated that ActVA-ORF5 and Gra-ORF21 are bifunc-
tional and capable of both p-quinone formation at
C-6 in the central ring and C-8 hydroxylation in the
lateral ring, whereas Med-ORF7 catalyzes only
p-quinone formation. No p-quinone formation on a
BIQ substrate was observed for AlnT, which is
involved in lateral p-quinone formation in ALN.
INTRODUCTION
Actinorhodin (ACT) 1 (Figure 1A) is a blue pigmented antibiotic
produced by Streptomyces coelicolor A3(2), which is genetically
the most characterized actinomycete (Bentley et al., 2002). This
compound belongs to a class of aromatic polyketides, the ben-
zoisochromanequinone (BIQ) antibiotics. Most importantly, ACT
1 is the first antibiotic whose whole biosynthetic gene cluster (the
act cluster) was cloned (Malpartida andHopwood, 1984) and has
served as an excellent model system for antibiotic biosynthesis
and its regulation. Recently, by taking advantage of the charac-
teristic blue color of ACT 1 that enables visual estimation of its
production, Craney and colleagues discovered small molecules
that modulate the yield of secondary metabolites (Craney et al.,
2012). This is a novel approach, potentially leading to drug dis-510 Chemistry & Biology 20, 510–520, April 18, 2013 ª2013 Elseviercovery by the activation of cryptic biosynthetic pathways (Ochi
and Okamoto, 2012).
From a biosynthetic point of view, much interest has focused
on the assembly of the basic carbon skeleton of ACT 1 catalyzed
by a type II polyketide synthase (PKS), and ancillary enzymes
(Das and Khosla, 2009, Beltran-Alvarez et al., 2007). A recent
example is provided by structural studies (Javidpour et al.,
2011) of the actIII ketoreductase (KR) at C-9, which controls
the regiospecific cyclization of a nascent polyketide chain
essential for the formation of the correct ACT ring system (Fig-
ure 1A). This enabled identification of key amino acid residues
that determine the stereospecificity of the reaction, and this in-
formation may be useful for the engineering of novel polyketide
backbones with greater structural diversity.
Later modification (tailoring) steps in ACT biosynthesis are
also of great interest from a chemical point of view. The oxidative
steps at C-6 in the central ring and C-8 in the lateral ring have
been studied intensively (Kendrew et al., 1997; Sciara et al.,
2003; Valton et al., 2004, 2006, 2008; Okamoto et al., 2009;
Taguchi et al., 2011). The principal enzyme involved in C-6
oxygenation is the ActVA-ORF5 flavin-dependent monooxyge-
nase (FMO), which forms a two-component enzyme system
in combination with the ActVB flavin:NADH oxidoreductase
(ActVA-ORF5/ActVB). Recently, we demonstrated that the
ActVA-ORF5/ActVB system functions as a quinone-forming oxy-
genase at C-6 in relation to the formation of dihydrokalafungin
(DHK) 2 (Okamoto et al., 2009, Figure 1A). At present, two other
complete biosynthetic gene clusters for BIQs have been cloned
and analyzed: granaticin (GRA) 3 (the gra cluster, Ichinose et al.,
1998) and medermycin (MED) 4 (themed cluster, Ichinose et al.,
2003). Because quinone formation at C-6 is common to all BIQ
biosyntheses (Figure 1B), it is not surprising that each gene clus-
ter carries a set of genes encoding two-component FMOs pre-
dicted to govern this oxygenation step (gra-ORF21/gra-ORF34
and med-ORF7/med-ORF13, respectively).
A newer example in this family is the alnT/alnH system found in
the biosynthetic gene cluster (aln) for alnumycin (ALN) 5 (Fig-
ure 1B), whose structure is closely related to that of the BIQs
(Oja et al., 2008). The ALN chromophore carries a p-quinone
arrangement in the lateral ring instead of the central ring,
implying a distinct difference in quinone formation between theLtd All rights reserved
AB
Figure 1. Overview of Actinorhodin
Biosynthesis
(A) Currently proposed biosynthetic pathway of
ACT. The numberings are based on the biosyn-
thetic order. ARO, aromatase; CYC, cyclase.
Dashed arrows indicate the shunt pathways.
(B) The structures of BIQ antibiotics, ALN,
and ALN-related compounds. DMAC, 3,8-dihy-
droxy-1-methylanthraquinone-2-carboxylic acid;
(S)-DNPA, 4-dihydro-9-hydroxy-1-methyl-10-
oxo-3-H-naphtho-[2,3-c]-pyran-3-(S)-acetic acid.
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expression system for the entire aln cluster, inactivation of alnT
was carried out to characterize a shunt product, thalnumycin A
(ThA) 6 (Figure 1B), which lacks the oxygen at C-7 of ALN 5 cor-
responding to C-8 of ACT 1 (Grocholski et al., 2012). An in vitro
conversion of ThA 6 into its p-hydroquinone derivative, thalnu-
mycin B (ThB) 7, by the AlnT/AlnH system was subsequently
demonstrated (Grocholski et al., 2012), clearly proving the
oxygenation activity of this system toward the lateral ring. The
absence of a pyran ring in the tricyclic structures of ThA 6 and
ThB 7 suggests a possible bicyclic intermediate as the true sub-
strate for the AlnT/AlnH system. It is noteworthy that the timing of
quinone formation catalyzed by AlnT/AlnH is earlier than those in
BIQ biosynthesis.
Although the hydroxyl group at C-8 in the lateral ring is
commonly found in some BIQs such as ACT 1 and GRA 3,
MED 4 lacks this substitution. The C-8 oxygenation in ACT
biosynthesis takes place after the C-6 oxygenation catalyzedChemistry & Biology 20, 510–520, April 18, 2013by the ActVA-ORF5/ActVB system. Inter-
estingly, the ActVA-ORF5/ActVB system
has also been implicated in the C-8
oxygenation step (Valton et al., 2006,
2008), although no in vivo evidence has
been provided.
The oxidative modifications of the poly-
ketide backbones of BIQs and ALN 5 are
thus strictly controlled in terms of number
and carbon position (ACT/GRA: C-6 and
C-8; MED: C-6; ALN: C-7), providing an
ideal model system for the functional
dissection of the FMOs involved in these
biosynthetic pathways. In this study, by
expressing these FMOs in an actVA-
ORF5 deletion mutant, we demonstrated
that ActVA-ORF5 and Gra-ORF21 are
bifunctional enzymes displaying both
C-6 and C-8 oxygenation activities. In
contrast, Med-ORF7 was shown to be a
monofunctional enzyme for C-6 oxygena-
tion. These results provide rare examples
of FMOs that catalyze oxidation reactions
at two different carbon atoms in the same
substrate molecule. In addition, we iden-
tified N-acetyl-cysteine (AcCys) adducts
of DHK 2 in the culture supernatants
from an actVA-ORF5 mutant expressingmed-ORF7. This is an intriguing example of the modification
and export of an unwanted metabolite that is not accumulated
in wild-type cells, presumably by recruiting the mycothiol-
dependent detoxification pathway found in actinobacteria
(Newton and Fahey, 2002).
RESULTS
Sequence Comparison among Aromatic
Two-Component FMOs
FMOs are classified into two types, either single-component
flavoprotein enzymes or two-component enzymes consisting
of a flavin:NAD(P)H oxidoreductase and a flavin-dependent
monooxygenase (van Berkel et al., 2006). Single-component
FMOs that use aromatic compounds as substrates (e.g., aro-
matic hydroxylase) have been extensively studied. In contrast,
only a few examples of two-component aromatic hydroxylases
have been characterized at themolecular level. Themost studiedª2013 Elsevier Ltd All rights reserved 511
Figure 2. In Vitro Quinone-Forming Activities of the Recombinant
FMOs
(A) SDS-PAGE analysis of the recombinant FMOs used for in vitro assay.
(B) Quinone-forming activities of the FMOs. Emodinanthrone was used as the
substrate. (a) boiled ActVA-ORF5/ActVB as negative control. A small amount
of emodin was spontaneously formed by autoxidation, (b) ActVA-ORF5/
ActVB, (c) Gra-21/ActVB, (d) Med-7/ActVB, (e) AlnT/ActVB, and (f) AlnT/AlnH.
Chromatograms monitored by absorbance at 254 nm are shown.
See also Figure S1 and Table S3.
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512 Chemistry & Biology 20, 510–520, April 18, 2013 ª2013 Elsevierenzyme is p-hydroxyphenylacetate 3-hydroxylase (HPAH) from
Acinetobacter baumannii, consisting of the flavin reductase
C1-hpah and the oxygenase C2-hpah (Thotsaporn et al.,
2004). We carried out sequence comparisons between the
FMOs of interest (ActVA-ORF5, Gra-ORF21, Med-ORF7, and
AlnT) and C2-hpah (Figure S1 available online). ActVA-ORF5,
Gra-ORF21, Med-ORF7, and AlnT proteins closely resembled
each other (47%–56% identity, 57%–66% similarity), but rela-
tively low sequence homologies between these FMOs and C2-
hpah were revealed (24%–27% identity, 42%–43% similarity).
Determination of the crystal structure of C2-hpah identified
conserved key amino acid residues predicted to be important
for monooxygenase activity: His-399 as a hydrogen-bond donor
to the oxygen atoms of the intermediate, Trp-210 for hydropho-
bic interaction with the flavin, and Ser-171 for hydrogen bonding
to the substrate (Alfieri et al., 2007). In addition, Phe-266 was
implicated in the binding of the A. baumanniiHPAH to p-hydroxy-
phenylacetate. Of these key residues, those relevant for catalysis
(His-399, Trp-210, and Ser-171) were all conserved in the FMOs
involved in the biosynthesis of BIQs and ALN 5. In contrast,
Phe-266 was not conserved but was replaced with Asn, implying
a different mode of substrate recognition between these FMOs
and C2-hpah (Figure S1).
Functional Analysis of ActVA-ORF5 and Its
Related FMOs
Sequence analysis of Gra-ORF21, Med-ORF7, and AlnT sug-
gested that these FMOs should have an activity(s) similar to
that of ActVA-ORF5. ActVA-ORF5 catalyzes both in vitro and
in vivo quinone formation in the central ring of three-ring aromatic
compounds (Okamoto et al., 2009). Furthermore, biochemical
studies indicated that ActVA-ORF5 can catalyze hydroxylation
at C-8 of the hydroquinone form of DHK 2 (Valton et al., 2006,
2008). We therefore decided to investigate whether these
enzymes catalyze both C-6 and C-8 oxygenations.
First, we performed an in vitro enzyme assay for quinone-
forming activity (Figure 2). For this purpose, we expressed
and purified the related FMOs as His-tagged forms (Figure 2A).
In the assay system, emodinanthrone was exploited as an
established model substrate, and the ActVB protein was
employed as a flavin:NADH oxidoreductase. High-performance
liquid chromatography (HPLC) analyses of reaction products
clearly demonstrated that ActVA-ORF5, Gra-ORF21, and
Med-7 have significant quinone-forming activity for the central
ring of this substrate (Figure 2B: b, c, and d). In contrast, AlnT
showed very weak activity (Figure 2B: e). This was not due to
incompatibility between AlnT and ActVB, because the use
of AlnH, the natural partner of this FMO, gave the same result
(Figure 2B: f).Ltd All rights reserved
AB
Figure 3. In Vivo Functional Analysis of ActVA-ORF5 and Rele-
vant FMOs
(A) The reverse sides of R5medium plates. Except for the wild-type strain, all
the others are in the DactVA-5,6 mutant background.
(B) HPLC chromatograms of the ACT-related metabolites from R5MS liquid
culture are shown. Chromatogramswere monitored by absorbance at 450 nm.
(a) DactVA-5,6 harboring pTYM1ep_His as negative control, (b) DactVA-5,6/
alnT, (c) DactVA-5,6/med-ORF7, (d) DactVA-5,6/gra-ORF21, (e) DactVA-5,6/
actVA-ORF5, and (f) M510 harboring pTYM1ep_His as positive control. Under
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Chemistry & Biology 20,Next, we conducted in vivo functional analysis. A mutant in
which the genes for both the major (actVA-ORF5) and minor
(actVA-ORF6) C-6 oxygenases are deleted (DactVA-5,6) pro-
duced no ACT 1: and accumulated a brown pigment, actino-
perylone (ACPL) 8: (Taguchi et al., 2008). The production of
ACPL 8: is explained by the prevention of C-6 oxygenation of
6-deoxy-dihydrokalafungin (DDHK) 9 followed by oxidative
dimerization (Figure 1A). Because actVA-ORF6 is not essential,
expression of actVA-ORF5 alone in this mutant restored ACT
production (Okamoto et al., 2009). Assuming that ActVA-
ORF5 catalyzes both C-6 and C-8 oxygenations, ectopic
expression of the bifunctional FMOs that have both activities
should result in the restoration of ACT production in the
DactVA-5,6 mutant. On the other hand, expression of the
monofunctional FMOs that catalyze only C-6 oxygenation
should give rise to the accumulation of DHK 2 and/or KAL 10
that have the C-6 quinone moiety but lack the C-8 hydroxyl
group.
Intriguingly, on R5 agar plates, introduction of gra-ORF21
into the DactVA-5,6 mutant (DactVA-5,6/gra-21) gave character-
istic purple pigmentation, indicative of ACT production (Fig-
ure 3A). On the other hand, the recombinant harboring
med-ORF7 (DactVA-5,6/med-7) showed more yellowish pig-
mentation compared with a control strain (DactVA-5,6/vector).
Considering the differences in the ultraviolet/visible spectra
among ACPL 8, DHK 2, and KAL 10 (Taguchi et al., 2008,
2011), the latter two compounds are likely produced by the
DactVA-5,6/med-7 strain. In contrast, expression of alnT in the
mutant (DactVA-5,6/alnT) had no obvious effect on pigmentation
(Figure 3A).
We carried out detailed metabolite analysis using R5MS
liquid culture, followed by HPLC and liquid chromatography-
electrospray ionizationmass spectrometry (LC-ESI-MS) analysis
of the supernatants of the cultures (Figure 3B). The control
strain (DactVA-5,6/vector) and the recombinant DactVA-5,6/
alnT gave essentially the same HPLC profiles, where ACPL 8:
is detected as the main metabolite, as expected from their
similar pigmentation on plates (Figure 3B: a and b). Introduction
of actVA-ORF5 successfully complemented the DactVA-5,6
mutant as described previously (Okamoto et al., 2009). Strik-
ingly, a small but detectable peak corresponding to g-ACT
11 appeared on the DactVA-5,6/gra-21 chromatogram (Fig-
ure 3B: d), suggesting partial restoration of ACT production. In
contrast, the DactVA-5,6/med-7 strain provided an interesting
HPLC profile, which displayed peaks of previously unidentified
DHK derivatives (12 and 13, see later) together with that of
KAL 10 (Figure 3B: c). Detection of these metabolites indicated
that Med-7 catalyzed quinone formation at C-6, but did not
restore ACT biosynthesis.
Together, these results strongly indicated that ActVA-ORF5
and Gra-ORF21 are bifunctional FMOs that catalyze both C-6
and C-8 oxygenations, whereas Med-ORF7 is a monofunctional
FMO catalyzing C-6 oxygenation of DDHK 9.our experimental conditions, ACPL 8 was eluted at 22.2 min, whereas the
lactonized derivatives of ACT 1, g-actinorhodin (g-ACT, 11) and g0-actino-
rhodin (g0-ACT) were eluted at 23.7 and 22.9 min, respectively. In (d), an
enlarged chromatogram depicting a peak of 11 is also shown.
See also Table S3.
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Figure 4. Production of DHK-OH by Coexpression of the Minimal
Gene Set for DDHK Biosynthesis and the FMOs under Study
HPLC analyses of metabolites produced by S. coelicolor CH999/pIJ5659 with
(a) gra-ORF21, (b) actVA-ORF5, (c) med-ORF7, and (d) vector control.
Chromatograms monitored by absorbance at 450 nm are shown. See also
Figure S4.
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the Formation of DHK-OH Demonstrates the
Bifunctional Activity of ActVA-ORF5 and Gra-ORF21
We previously demonstrated the formation of ACPL 8 by ex-
pressing the minimal gene set (pIJ5659) for the production of
DDHK 9 in the act cluster-deficient strain, S. coelicolor CH999
(CH999/pIJ5659) (Okamoto et al., 2009). We took advantage of
this system to detect 8-hydroxy-dihydrokalafungin (DHK-OH)
14 (Taguchi et al., 2012), the most probable product arising
from the bifunctional activity of ActVA-ORF5 and Gra-ORF21
(Figure 1A). The gene for each FMO was introduced into
CH999/pIJ5659 followed by HPLC and LC-ESI-MS analysis of
ACT-related metabolites.
As expected, the recombinant carrying actVA-ORF5 produced
DHK-OH 14: (Figure 4: b), proving the C-8 oxygenation activity of
ActVA-ORF5. Introduction of gra-ORF21 also resulted in the pro-
duction of DHK-OH 14 (Figure 4: a). In contrast, expression of514 Chemistry & Biology 20, 510–520, April 18, 2013 ª2013 Elseviermed-7 in CH999/pIJ5659 led to the detection of DHK 2, but
not DHK-OH 14 (Figure 4: c).
Taken together, the combined data unambiguously demon-
strate the bifunctional activity of ActVA-ORF5 and Gra-ORF21
for C-6 and C-8 oxygenation and the monofunctional activity of
Med-7 for C-6 oxygenation in BIQ biosynthesis.
Structures of Metabolites from the Recombinant
DactVA-5,6/med-7
As described above, the DactVA-5,6 mutant expressing med-
ORF7 produced two unidentified ACT-related metabolites, 12,
and 13. LC-high-resolution (HR)-ESI-MS analysis of the two
compounds gave an identical molecular formula of
C21H21NO9S (m/z [M-H]
- calcd for C21H20NO9S, 462.0859.
found, 462.0868 [12], 462.0853 [13]), indicating that these
ACT-related compounds unexpectedly contained sulfur and ni-
trogen atoms. Therefore we carried out structure elucidation of
the two compounds, which were purified from the culture super-
natants of DactVA-5,6/med-7 with final yields of 7.9 mg (12) and
1.8 mg (13) as described in the Experimental Procedures.
1H- and 13C-nuclear magnetic resonance (NMR) signals of 12:
in acetone-d6 revealed their close resemblance to those of DHK
2 (Taguchi et al., 2011), except for the signals for C-4 (Table 1;
Table S1). Integration of 1H-NMR signals indicates the loss of
one hydrogen atom at C-4 in comparison to DHK2, and the re-
maining proton signal (dH = 4.08) was a doublet, which shows
a heteronuclear multiple bond correlation (HMBC) to the newly
observed methylene peak (dC = 34.7; dH = 3.06, 3.32). HMBC in-
dicates the connectivity of this carbon with methine (dC = 53.1;
dH = 4.60), which in turn correlates with the N-H proton (dH =
7.39) in 1H-COSY. These data as well as the additional signals
derived from acetyl (dC = 22.5, 170.4; dH = 2.49) and carboxyl
(dC = 172.1) groups indicated the existence of an N-acetyl
cysteine (AcCys) moiety in this molecule. Consequently, the
combined spectroscopic data suggested compound 12 to be
4-(N-acetyl-cysteinyl)-dihydrokalafungin (4-AcCys-DHK). There
are two possible configurations for the 4-AcCys substitution,
namely 4R-AcCys-DHK 12 and 4S-AcCys-DHK 13. The ob-
served coupling constant between the C-4 and C-3 protons
was 2.0 Hz, allowing their dihedral angle to be predicted as either
60 or 110 based on the Karplus equation. To evaluate the
C-4 stereochemistry of 4-AcCys-DHK, three-dimensional struc-
tures of the two possible products, 4R-AcCys-DHK 12 and 4S-
AcCys-DHK 13, were generated by computational modeling
(Figure S2). The dihedral angles of 4-H_3-H were calculated as
53.8 for 4R-AcCys-DHK 12 and 158.9 for 4S-AcCys-DHK 13,
indicating that the first unidentified compound was more likely
to be 4R-AcCys-DHK 12 (Figures 5A and S2).
Next we proceeded to determine the structure of the second
unknownmetabolite. Unexpectedly, even though the compound
was very similar in structure to 12, the sample was almost insol-
uble in acetone and therefore the NMR measurements were
carried out in methanol-d4. Although the
1H-NMR spectrum pro-
vided similar signals to those of 12, the observed signals
changed gradually in a time-dependent manner (data not
shown). HPLC analysis of the NMR sample recovered from an
NMR tube revealed the conversion of 13 to 15, which appeared
to be stable in methanol. Considering the feasibility of the
measurement, we then carried out the spectroscopic analysisLtd All rights reserved
Table 1. NMR Data of the Metabolites from DactVA-5,6/med-7, DHK, and KAL
Position
4R-AcCys-DHK 4R-AcCys-KAL DHKa KALa
13C d (ppm) 1H d (ppm) 13C d (ppm) 1H d (ppm) 13C d (ppm) 1H d (ppm) 13C d (ppm) 1H d (ppm)
1 172.0 174.3 171.9 175.2
2 38.3 2.87 35.2 2.55 40.7 2.58 37.3 2.49
2.95 3.41 2.70 3.19
3 68.0 4.58 74.4 4.80 64.3 4.35 67.7 4.87
4 40.8 4.08 83.4 – 28.4 2.29 69.7 5.34
2.83
5 143.9 – 138.1 – 143.6 – 136.4 –
6 182.5 – 181.4 – 183.5 – 182.5 –
7 133.0 – 133.3 – 132.9 – 132.7 –
8 119.8 7.63 120.0 7.64 119.4 7.56 119.7 7.65
9 137.5 7.76 138.0 7.71 137.3 7.71 138.0 7.80
10 125.0 7.30 124.6 7.32 124.6 7.26 125.0 7.34
11 166.8 11.98 162.0 11.74 161.9 11.97 162.4 11.84
12 115.9 – 115.8 – 115.7 – 116.0 –
13 190.2 – 185.5 – 189.7 – 189.6 –
14 144.8 – 148.9 – 146.7 – 150.3 –
15 68.2 4.95 67.6 5.06 67.5 4.93 67.0 5.04
16 19.1 1.55 18.0 1.64 19.6 1.54 18.5 1.58
10 172.1 – 171.7 – – – – –
20 53.1 4.60 52.9 4.66 – – – –
20 NH – 7.39 – 7.42 – – – –
30 34.7 3.06 33.0 3.33 – – – –
3.32 3.48 – – – –
N-Ac-Me 22.5 2.49 22.6 1.91 – – – –
N-Ac-CO 170.4 – 170.2 – – – – –
aTaguchi et al., 2011.
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(m/z [M-H] calcd for C21H18NO9S, 460.0702. found, 462.0689)
in LC/HR-ESI-MS analysis, which indicated the loss of two
hydrogen atoms in comparison to the original unstable com-
pound 13. The 1H-NMR spectrum of pure 15 resembled that of
KAL 10 (Taguchi et al., 2011) (Table 1). Comparison of signals be-
tween the two spectra revealed that the hydrogen atom at C-4 of
KAL 10was lacking, suggesting a substitution of one 4-H with an
AcCys moiety. In effect, all of the NMR signal assignments and
related correlations in two-dimensional NMR were reasonably
explained by the structure of 4R-AcCys-KAL 15 (Tables 1 and
S2; Figures 5B and S3). Considering the stereospecific lactoni-
zation of DHK to KAL from the b-face of the pyran ring, we could
conclude the 4R-configuration of 15 to be reasonable. On the
other hand, 4R-AcCys-DHK 12 in which the reactive position
for lactonization is substituted with AcCys, was chemically sta-
ble as mentioned above. Altogether, these experiments led to
the conclusion that the second unstable compound was 4S-Ac-
Cys-DHK 13.
DISCUSSION
In this study, we functionally analyzed the two-component FMOs
(ActVA-ORF5, Gra-ORF21, and Med-ORF7) conserved in theChemistry & Biology 20,biosynthetic gene clusters for BIQs. In addition, we also charac-
terized a similar FMO (AlnT) found in the biosynthetic gene clus-
ter for ALN 5, whose chemical structure is closely related to that
of BIQs (Oja et al., 2008). Because of significant sequence
homology among these FMOs (Figure S1), they were thought
to serve similar functions in the biosynthesis of the respective
compounds.
ActVA-ORF5 catalyzes oxygenation at C-6, which results in
formation of the p-quinone in the central ring of ACT 1 (Okamoto
et al., 2009). Because all BIQ molecules show the same
p-quinone arrangement, Gra-ORF21 and Med-ORF7 should be
involved in the equivalent biosynthetic steps. Indeed, we demon-
strated the in vitro quinone-forming activities of these two FMOs,
as well as ActVA-ORF5, at the central ring of emodinanthrone
(Figure 2B: c and d). Recently, AlnT was shown to be involved
in formation of the p-quinone arrangement in the lateral ring in
ALN 5 (Grocholski et al., 2012). Therefore, it was of great interest
to investigate whether AlnT uses emodinanthrone as a substrate
and catalyzes quinone formation at the central ring. Notably,
AlnT was incapable of quinone formation at the lateral ring in
this model substrate, confirming the different regiospecificity of
this enzyme (Figure 2B: e and f).
The involvement of the actVA genes in C-8 hydroxylation was
initially implicated by the fact that pIJ2315, which carries a DNA510–520, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 515
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Figure 5. Structures of Compounds 12, 13, and 15
(A) The elucidated structure of compound 12 as 4R-(N-acetyl-cysteinyl)-dihydrokalafungin (4R-AcCys-DHK).
(B) The deduced structure of compound 13 from compound 15, 4R-(N-acetyl-cysteinyl)-kalafungin (4R-AcCys-KAL).
(C) A proposed mechanism of AcCys moiety addition to DHK2 recruiting mycothiol17.
See also Figures S2 and S3; Tables S1 and S2.
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Oxygenases for Actinorhodin and Its Relativesfragment spanning actVA-ORF1 to -ORF5, caused the produc-
tion of the hybrid antibiotic, mederrhodin A (8-hydroxymedermy-
cin), in the medermycin producer, Streptomyces sp. AM-7161
(Hopwood et al., 1985). Later, significant sequence similarity
between ActVA-ORF5 and certain aromatic hydroxylases was
revealed (Caballero et al., 1991; Valton et al., 2004). Recently,
Valton and colleagues (Valton et al., 2006, 2008) observed an
in vitro C-8 hydroxylation activity of ActVA-ORF5 under anaer-
obic conditions using the hydroquinone form of DHK 2 as a
substrate. Our recent studies (Okamoto et al., 2009) have
demonstrated that the act gene cluster encodes two alternative
enzymes for C-6 oxygenation, namely, ActVA-ORF5 and ActVA-
ORF6. Of these enzymes, ActVA-ORF5, but not ActVA-ORF6,
was shown to be essential for ACT biosynthesis (Okamoto
et al., 2009). This finding implies that ActVA-ORF5 should have
an additional function other than C-6 oxygenation activity.
ACT 1 and GRA 3 possess the hydroxyl group at C-8, whereas
MED 4 lacks this substitution. If these structural variations in
BIQs are attributable to differences in the function of the
FMOs, ActVA-ORF5 and Gra-ORF21 should have both C-6
and C-8 oxygenation activities, while Med-ORF7 should only
be active for C-6 oxygenation. Based on the presumed sub-
strate, DDHK 9, for ActVA-ORF5 and Med-ORF7 (Ichinose
et al., 2003; Okamoto et al., 2009), the substrate for Gra-
ORF21 is thought to be 6-deoxy-nanaomycin A (DNNM_A 16),
the enantiomer of DDHK 9 (Ichinose et al., 1998) (Figure 6). There
is a possibility that DDHK 9 may serve as a substrate for
Gra-ORF21. Moreover, although the cognate flavin:NADH oxi-
doreductases are required for the proper functions of the two-
component FMOs, ActVB was expected to substitute for these
flavin reductases because a thermodynamic transfer of the
reduced flavin from ActVB to ActVA-ORF5 without involving a516 Chemistry & Biology 20, 510–520, April 18, 2013 ª2013 Elsevierspecific physical interaction between the two proteins has
been demonstrated (Valton et al., 2004, 2008). Therefore, we
took advantage of the DactVA-5,6 mutant (Okamoto et al.,
2009; Taguchi et al., 2008) and investigated the effects of ectopic
expression of these FMOs on the production of the ACT-related
metabolites. AlnT did not alter the metabolic profile of this
mutant, consistent with the in vitro result. Strikingly, expression
of Gra-ORF21 as well as ActVA-ORF5 restored ACT production
in the DactVA-5,6 mutant (Figure 3). On the other hand, expres-
sion of Med-ORF7 was incapable of restoring ACT production
and led to the accumulation of KAL 10, 4R-AcCys-DHK 12, and
4S-AcCys-DHK 13, all of which have the p-quinone moiety in
the central ring (Figures 3 and 5). These findings clearly demon-
strated the monofunctional activity of Med-ORF7 for C-6
oxygenation and strongly suggest the bifunctional activity of
ActVA-ORF5 and Gra-ORF21 for both C-6 and C-8 oxygenation.
To confirm their bifunctionality, we utilized the minimal gene
set leading to the production of DHK-OH 14 that is thought to
arise from the stepwise oxygenations at C-6 and C-8 of DDHK
9. In the biosynthesis of ACT 1, the type II polyketide synthase
(ActI-ORF1, -ORF2, and -ORF3) assembles a basic carbon
skeleton, which undergoes modification by the ketoreductase
(ActIII), aromatase (ActVII), cyclase (ActIV), and stereospecific
reductases (ActVI-ORF1 and ActVI-ORF2) to afford DDHK 9.
We have demonstrated the biosynthesis of DDHK 9 in vivo by ex-
pressing a suite of these enzymes from a plasmid (pIJ5659: see
Figure S4) in the act cluster-deficient strain, CH999 (Okamoto
et al., 2009). pIJ5659 is a derivative of pRM5 (McDaniel et al.,
1993), which utilizes the native genetic segment of the act cluster
covering the act-III, -I, -VII, -IV, and -VB regions. Because the
actVB gene is located on this plasmid, the expression of
the monooxygenase component will result in the formation ofLtd All rights reserved
Figure 6. Proposed Later Tailoring Steps in the Biosyntheses of ACT, GRA, and MED
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Oxygenases for Actinorhodin and Its Relativesthe functional two-component FMO in CH999/pIJ5659. Expres-
sion of Med-ORF7 in this strain led to the production of DHK 2,
again demonstrating the C-6 oxygenation activity of this FMO.
As expected, CH999/pIJ5659 expressing ActVA-ORF5 pro-
duced DHK-OH 14. Furthermore, expression of Gra-ORF21
also resulted in the production of DHK-OH 14, although at lower
yields. Given the opposite stereochemistry of the pyran ring in
DDHK 9 and DNNM_A 16 (Taguchi et al., 2001), this result could
be reasonably explained by the stereochemical recognition of
DDHK 9 as an unnatural substrate by Gra-ORF21. Taken
together, our data unambiguously demonstrate the bifunctional
activity of ActVA-ORF5 and Gra-ORF21 for C-6 and C-8 oxygen-
ations in the biosynthesis of these BIQs.
Our results indicate that a single FMO system, ActVA-ORF5/
ActVB, catalyzes oxidation reactions at two different carbon
atoms in the same substrate molecule. This is a rare example
among known regiospecific monooxygenases involved in the
biosynthesis of natural products. For example, seven dedicatedChemistry & Biology 20,P450 genes were found for the eight necessary oxygenation
reactions in taxol biosynthesis (Kaspera and Croteau, 2006).
However, few multifunctional monooxygenases involved in sec-
ondary metabolism have been identified. Particularly noteworthy
examples are single-component flavoprotein oxygenases, PgaE
(Kallio et al., 2011; Patrikainen et al., 2012) and TcmG (Rafanan
et al., 2000), involved in the biosynthesis of gaudimycins and
tetracenomycin, respectively. PgaE was demonstrated to cata-
lyze sequential C-12 and C-12b hydroxylations of 2,3-dehydro-
UWM6 (Kallio et al., 2011), while TcmG has been implicated in
three hydroxylation reactions (Rafanan et al., 2000). In terms
of repetitive functionality related to oxygenation, GilOII was
recently demonstrated to be involved in the oxidative C-C
bond-cleavage reaction in the biosynthesis of Gilvocarcin V (Ti-
brewal et al., 2012).
The recombinant DactVA-5,6/med-7 produced two unique
metabolites, 12 and 13, which turned out to be the 4R- and
4S-AcCys adducts of DHK 2, respectively. Meanwhile, the510–520, April 18, 2013 ª2013 Elsevier Ltd All rights reserved 517
Chemistry & Biology
Oxygenases for Actinorhodin and Its Relativesrecombinant CH999/pIJ5659 carryingmed-7 accumulated no 4-
AcCys-DHKs, probably due to its low productivity (30% of
DHK-related metabolites, 10, 12, and 13, in DactVA5,6/med-7)
of DHK 2 or differences in the genetic background. Mycothiol
(MSH 17) is the major thiol compound present in certain gram-
positive bacteria, including streptomycetes. It is comprised of
AcCys amide-linked to 1-D-myo-inosytyl 2-amido-2-deoxy-
a-D-glucopyranoside (GlcN-Ins). MSH 17 has analogous
functions to glutathione and is involved inmany biochemical pro-
cesses that protect cells against the toxicity of oxygen and reac-
tive electrophiles (Newton and Fahey, 2002) (Figure 5). This
unique thiol can react with various toxic compounds and form
MSH S-conjugates. The MSH S-conjugates are then cleaved
by a MSH S-conjugate amidase (Mca) to release GlcN-Ins and
a toxin-AcCys S-conjugate, which in turn is excreted from the
cell. The identification of 4-AcCys-DHKs from the recombinant
DactVA-5,6/med-7 implies that DHK 2 is somewhat toxic to
S. coelicolor and is excreted from the cell by recruiting the
MSH-dependent detoxification pathway. In S. coelicolor A3(2),
the genes encoding MSH biosynthetic enzymes (MshA, B, C,
and D) and Mca have been identified, and genetically character-
ized (Park et al., 2006, Park and Roe, 2008). To establish the role
of the MSH-dependent detoxification pathway in the formation
of 4-AcCys-DHKs, genetic and biochemical characterization of
these genes has recently been initiated.
Most recently, we identified DHK-OH 14 and the related
metabolite, hydroxy-tetrahydroxykalafungin (THK-OH 18), from
a deletion mutant of the actVA-ORF4 gene (DactVA-4) (Taguchi
et al., 2012). These compounds correspond to the monomeric
unit of ACT 1, and their isolation clearly indicates the critical
role of ActVA-ORF4 in the dimerization step of ACT biosyn-
thesis. The structural equivalence of THK-OH 18 to its tetrahy-
doroxynaphthalene form (THN) 19 prompted us to propose a
reasonable scheme for the sequential aromatic hydroxylation
reactions of DDHK 9 at C-6 and C-8 to afford THN 19 (Fig-
ure 6). We and others have confirmed that, in vitro, DHK 2
itself is not a suitable substrate for C-8 hydroxylation (Taguchi
et al., 2011; Valton et al., 2006). Consistent with this notion,
the hydroquinone form of DHK 2 has been shown to be a
good substrate for the C-8 hydroxylation reaction catalyzed
by ActVA-ORF5 under anaerobic conditions (Valton et al.,
2006). The fact that DHK-OH 14 was detected from a recombi-
nant CH999/pIJ5659 carrying actVA-ORF5 also strongly sup-
ports this proposal.
Based on the possible ortho- and para-directing effect of the
11-hydroxyl group, it has been thought that the regiospecific
dimerization at C-10 takes place prior to C-8 hydroxylation (Fig-
ure 1A, route A). However, identification of DHK-OH 14 in the
strains deficient in the dimerization step (i.e., DactVA-4 and
CH999/pIJ5659 carrying actVA-ORF5) clearly showed that C-8
hydroxylation occurs before the completion of this step (Figures
1A, route B, and 6). Importantly, we have not been able to detect
any dimerized metabolites derived from DHK 2 or KAL 10 from
the DactVA-5,6 mutant expressing Med-ORF7, in which the
dimerization pathway is most likely to be functional. Taken
together, we propose that the dimerization reaction of ACT
monomers takes place after C-8 hydroxylation. Investigation of
the mechanism of this regiospecific C-C dimerization, here
shown to be the last step of ACT biosynthesis, is in progress.518 Chemistry & Biology 20, 510–520, April 18, 2013 ª2013 ElsevierSIGNIFICANCE
The two-component flavin-dependent monooxygenases
(FMOs) for the biosynthesis of actinorhodin (ACT) and
related antibiotics, including granaticin (GRA), medermycin
(MED), and alunumycin (ALN), were revealed to show
distinct functional specificities leading to the production of
the respective compounds. The most intriguing finding is
that ActVA-ORF5 and Gra-ORF21 are bifunctional enzymes
capable of catalyzing oxygenation reactions at both the
central (C-6) and lateral (C-8) rings of a tricyclic substrate.
This is a rare example found in secondary metabolism,
where a single monooxygenase catalyzes oxygenations at
two different carbons in the same substrate. Despite signif-
icant homology to these FMOs, Med-ORF7 and AlnT are
monofunctional and catalyze oxygenation either at the
central ring (Med-ORF7) or the lateral ring (AlnT), respec-
tively. Heterologous expression of Med-ORF7 in place of
ActVA-ORF5 in Streptomyces coelicolor led to the accumu-
lation of dihydrokalafungin and itsN-acetyl cysteine (AcCys)
adducts, all of which have the C-6 quinone moiety but lack
the C-8 hydroxyl group, leading to two implications. First, a
defect in the C-8 oxygenation step blocks the subsequent
biosynthetic steps toward ACT production, including C-C
dimerization at C-10. A bona fide substrate for the dimeriza-
tion reaction is likely to be a derivative of 1,4,5,8-tetrahy-
droxynaphthalene, raising an interesting question: how is a
symmetrical aromatic ring system coupled in a regiospecific
manner? This could be a novel situation, where the enzyme
recognizes features far from the part of the molecule being
acted on to control the regiospecificity. Second, the accu-
mulation of the AcCys adducts is an example of the export
of unwantedmetabolites by recruiting themycothiol-depen-
dent detoxification pathway, which makes the recombinant
strain an excellent model system for further studies on the
detoxification and export of particular secondary metabo-
lites in Streptomyces and other related bacteria.
EXPERIMENTAL PROCEDURES
General
LC/ESI-TOF-MS analysis was carried out on a Waters AllianceHT equipped
with photo-diode array detector (Waters 2995). Mass spectrometry data
were obtained under electron spray ionization (ESI) on a Waters LCT-Premier.
HPLC analysis was performed on a TOSOH SC8020 system using a photo-
diode array detector. Optical rotation was measured on a JASCO P-1010
digital polarimeter. NMR spectra were obtained on a JEOL ECX400 spectrom-
eter (400 MHz for 1H; 100 MHz for 13C) in acetone-d6.
1H and 13C chemical
shifts were referenced to the solvent signals (dH 2.04 and dC 29.8 for
acetone-d6, dH 3.30 and dC 49.0 for methanol-d4).
Chemicals
All chemicals unless otherwise stated were reagent grade purchased from
Wako Pure Chemical Industries or Sigma-Aldrich.
Bacterial Strains
S. coelicolor M510 (M145 DredD) (Floriano and Bibb, 1996) and the DactVA-
5,6 mutant (Okamoto et al., 2009) were used for in vivo functional analysis.
S. coelicolor CH999 (proA1 argA1 redE60 Dact::ermE SCP1 SCP2)
harboring pIJ5659 (Ichinose et al., 1999) was also used for expression of
minimal gene sets. Escherichia coli DH5awas used for routine DNAmanipula-
tion. E. coli BL21(DE3)/pLysS was used as the host for protein expression.Ltd All rights reserved
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Plasmid isolation, restriction enzyme digestion, ligation, and transformation of
E. coli and S. coelicolor were performed as described previously (Kieser et al.,
2000; Sambrook et al., 1989). Plasmids were introduced into the S. coelicolor
strains by conjugation with E. coli strain GM2929/pUB307::Tn7 (Kieser et al.,
2000). PCR was performed with KOD FX (Toyobo, Japan) DNA polymerase.
PCR primers used in this study are listed in Table S3.
Plasmids
The genes encoding individual FMOs were amplified by PCR, TA-cloned into
the pTA2 vector (Toyobo, Japan), and sequenced. These plasmids were
used for the construction of both E. coli and Streptomyces expression
plasmids.
The E. coli expression plasmids used for purification of recombinant pro-
teins were constructed as follows: each FMO gene was excised from the
pTA2 derivatives as the NdeI-BamHI (med-ORF7 and alnT) or NdeI-
Bpu1102I (gra-ORF21) fragments and cloned into pET-19b. The E. coli expres-
sion plasmids thus obtained attach the N-terminal His-tag sequence.
The Streptomyces expression plasmids were constructed as follows: the
FMO genes were excised by digestion with NdeI and XbaI and inserted into
an integrative expression plasmid pTYM1ep_His (M.Y., T.A., T.T., K.I., and
S.O., unpublished data; Onaka et al., 2005) that has a constitutive ermE* pro-
moter. These expression constructs also attach the N-terminal His-tag
sequence.
Expression of Recombinant FMOs and In Vitro Assay
Expression and purification of recombinant FMOs was performed as
described earlier for ActVA-ORF5 (Okamoto et al., 2009), except that the
expression of the genes was induced at 25C for 5 hr.
Quinone-forming activity for emodinanthrone was measured as described
previously (Okamoto et al., 2009). The assay mixture (500 ml) contained 1 mM
of FMO and 0.2 mM of ActVB. The reaction was quenched with CH3CN
(250 ml) and centrifuged at 13,200 3 g for 2 min. The supernatant (75 ml) was
subjected to reversed-phase HPLC analysis.
Culture Conditions for Metabolites Analysis
Strains were inoculated on R5- medium (Huang et al., 2001) plates and grown
at 30C for 4 days. For liquid culture and metabolite analyses, seed cultures
(10 ml) were grown in TSB medium (Kieser et al., 2000) on a rotary shaker at
200 rpm and 30C for 2 days. An aliquot (2 ml) of the seed culture was inocu-
lated into 100 ml of R5MS medium (Okamoto et al., 2009) in a 500-ml
Erlenmyer flask, and grown with shaking (200 rpm) at 30C for 5 days. R5
medium was used for solid cultures. For the culture of CH999 transformants,
R5MS medium was supplemented with L-histidine (50 mg/ml) and L-proline
(37.5 mg/ml).
LC-ESI-TOF-MS Analysis
An aliquot of culture (1 ml) was centrifuged at 13,2003 g for 5 min. The super-
natant (50 ml) was directly subjected to reverse-phase LC-ESI-time-of-flight
(TOF)-MS analysis under the following conditions: column, TSK gel ODS-
100S (4.6 id3 150 mm, TOSOH); column temperature, 40C; gradient elution,
solvent A (0.1% formic acid in CH3CN) and solvent B (0.1% formic acid in
deionized H2O), gradient profile: 0-35 min, 10%–95%A; 35–40 min, 95%A;
40–45min, 95%–10%A; flow rate, 1.0 ml/min; detection, absorbance between
250 and 600 nm.
Isolation of Compounds
To culture broth of theDactVA-5,6mutant carryingmed-ORF7 (2.6 l) separated
frommycelium by centrifugation, DIAIONHP-20 (Mitsubishi Chemical) (450ml)
was added and incubated for 1 hour at room temperature. HP-20 was
collected by filtration, washed with water (2.6 l), and eluted with 50% aq.
MeOH (2.6 l). The 50% aq. MeOH eluent was adjusted to a final concentration
of 25%MeOH and 0.1% formic acid. An aliquot (50 ml) of the resultant diluted
eluent was repeatedly applied to an equilibrated ODS column (SepPak vac
6 cc, Waters), followed by wash with 25% aq. MeOH containing 0.1% formic
acid (10 ml) and elution with 60% aq. MeOH containing 0.1% formic acid
(10 ml, twice). The 60% aq. MeOH fractions were collected, concentrated in
vacuo, and partitioned with ethyl acetate. The ethyl acetate extract (62 mg),Chemistry & Biology 20,containing compound 12 and 13, was further purified by preparative HPLC
under the flowing conditions: column, TSK gel ODS-100S (7.8 id 3 300 mm,
TOSOH); column temperature, 50C; solvent: 55% aq. methanol containing
0.1% formic acid; flow rate, 2.0 ml/min; detection, absorbance between
250 and 600 nm, to afford pure 4R-AcCys-DHK (7.8 mg), 4S-AcCys-DHK
(1.8 mg), and 4R-AcCys-KAL (4.2 mg). Optical rotations were determined
as follows: [a]D +355.5
 (c 0.22, MeOH) for 4R-AcCys-DHK, [a]D 2.0
(c 0.17, MeOH) for 4S-AcCys-DHK, and [a]D 64.5 (c 0.21, MeOH) for 4R-
AcCys-KAL.
Computational Modeling
The three-dimensional structures of 4-AcCys-DHKs and 4R-AcCys-KAL were
constructed by employing Molecular Operating Environment (MOE), 2010.10
(Chemical Computing Group, Canada). To the resultant structures, partial
charges were applied and then the Systematic Conformational Search algo-
rithm in the MOE package was carried out in the force field, MMFF94x. This
algorithm generated six lowest energy candidates within 7 kcal/mol for 4R-
AcCys-DHK, 13 candidates for 4S-AcCys-DHK, and two candidates for 4R-
AcCys-KAL, respectively, and the most stable models are shown in Figures
S2 and S3.
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